Johnson & Johnson COVID-19 Vaccine Granted Conditional Marketing Authorisation Amendment for Use as Booster Dose by European Commission
- EMEA Innovative Medicine
- Johnson & Johnson COVID-19 Vaccine Granted Conditional Marketing Authorisation Amendment for Use as Booster Dose by European Commission
Johnson & Johnson COVID-19 Vaccine Granted Conditional Marketing Authorisation Amendment for Use as Booster Dose by European Commission
-
X (Twitter) -
LinkedIn -
Pinterest -
Copy link